VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 7, 2017) - Amarillo Gold Corp. (TSX VENTURE:AGC) ("Amarillo" or the "Company") is pleased to announce the results of an updated Pre-feasibility Study ("PFS" or "Study") in accordance with National Instrument 43-101 ("NI 43-101")...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 7, 2017) - In the news release "Amarillo Gold's Updated Pre-Feasibility Study at Mara Rosa delivers Post Tax IRR of 35% with a 2.2 year payback @ $1200/oz Au," issued earlier today by Amarillo Gold Corp. (TSX VENTURE:AGC), we...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2017) - Amarillo Gold Corp. (TSX VENTURE:AGC) ("Amarillo" or the "Company"), is pleased to announce that it has filed the updated Pre-feasibility ("PFS" or "Study") report for the Posse gold deposit within its 100% owned Mara...Read More
VANCOUVER, British Columbia, June09, 2017(GLOBE NEWSWIRE) -- Amarillo Gold Corp. (TSX-V:AGC) ("Amarillo") is pleased to announce the appointment of Rolly Uloth to the Board of Amarillo as the Executive Chairman. Mr. Rolly Uloth is a seasoned mining executive with almost 20 years experience in va...Read More
VANCOUVER, July 19, 2016 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB:AXREF) announces that new option agreements have been negotiated with respect to the Galore Property with Galore Resources Inc. ("Galore") and Underlying Owners. Under the new agreements Amarc ca...Read More
VANCOUVER, Aug. 2, 2016 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB: AXREF) is pleased to announce that exploration work has commenced at the new IKE porphyry copper-molybdenum-silver discovery and surrounding district.Core drilling combined with regional geological,...Read More
DRILLING INTERSECTS 148 METRES OF 0.53% CuEQ @ 0.39% Cu, 0.03% Mo and 2.8 g/t Ag VANCOUVER, Oct. 17, 2016 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB: AXREF) is pleased to announce results from the 2016 field programs at the IKE porphyry copper-molybdenum-silver d...Read More
VANCOUVER, Nov. 21, 2016 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB: AXREF) is pleased to announce it plans to acquire a 100% interest in two important-scale porphyry copper deposit targets located in north-central and central British Columbia ("BC") respectively,...Read More
VANCOUVER, Jan. 11, 2017 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB: AXREF) announces that Thompson Creek Metals Company Inc. ("TCMC"), which was recently acquired by gold-focused Centerra Gold Inc., has relinquished its option to earn up to a 50% interest in the IK...Read More
ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the year ended December 31, 2016. Fourth quarter and subsequent operational highlight...Read More
(TheNewswire) Toronto, ON / TheNewswire / April 21, 2017 - At the request of IIROC, Alturas Minerals Corp. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Alturas Mine...Read More
GAITHERSBURG, Md., May04, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ C...Read More
GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More
GAITHERSBURG, Md., June19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the BIO International Convention, taking place...Read More
Toronto, Ontario--(Newsfile Corp. - April 10, 2017) - Accilent Capital Management Inc. ("ACM") announces that ACM remains an insider of Alto Ventures Ltd. ("Alto") based on direction and control over shares of Alto despite reporting otherwise on April 5th, 2017.ACM exercises control or direction ove...Read More